Bayesian Capital Management’s Constellium CSTM Stock Holding History

Bayesian Capital Management’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,100	Closed	-$165K	–	213
2025 Q3	$165K	Buy	+11,100	New	+$159K	0.03%	474
2025 Q2	–	Sell	-71,000	Closed	-$716K	–	608
2025 Q1	$716K	Buy	+71,000	New	+$755K	0.12%	234
2023 Q1	–	Sell	-12,800	Closed	-$151K	–	850
2022 Q4	$151K	Buy	+12,800	New	+$150K	0.02%	630
2022 Q3	–	Sell	-17,499	Closed	-$231K	–	748
2022 Q2	$231K	Buy	17,499 +6,700	+62%	+$107K	0.04%	577
2022 Q1	$194K	Buy	+10,799	New	+$197K	0.03%	655
2020 Q3	–	Sell	-29,600	Closed	-$227K	–	549
2020 Q2	$227K	Sell	29,600 -52,400	-64%	-$381K	0.05%	414
2020 Q1	$427K	Buy	+82,000	New	+$881K	0.09%	337
2019 Q4	–	Sell	-16,400	Closed	-$208K	–	621
2019 Q3	$208K	Buy	+16,400	New	+$193K	0.04%	437
2019 Q1	–	Sell	-41,353	Closed	-$289K	–	585
2018 Q4	$289K	Buy	41,353 +21,600	+109%	+$192K	0.06%	420
2018 Q3	$244K	Buy	+19,753	New	+$231K	0.04%	507
2018 Q2	–	Sell	-20,350	Closed	-$221K	–	620
2018 Q1	$221K	Buy	20,350 +2,050	+11%	+$25K	0.06%	471
2017 Q4	$204K	Buy	+18,300	New	+$195K	0.04%	489

Other funds holding CSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bayesian Capital Management's CSTM Position: Q4 2025 in Review

Bayesian Capital Management sold out of Constellium (CSTM) in Q4 2025, closing a stake of 11,100 shares — an estimated $165K sold.

Bayesian Capital Management first reported a position in CSTM in Q4 2017 and held it in 12 quarters. The position peaked at $716K in Q1 2025. 253 funds tracked by Wall St. Rank hold CSTM as of Q4 2025.

Bayesian Capital Management reported no remaining Constellium position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 11,100 Constellium shares in Q4 2025, an estimated $165K.
Bayesian Capital Management first reported a position in Constellium in Q4 2017 and held it in 12 quarters.
Bayesian Capital Management's Constellium position peaked at $716K in Q1 2025.
253 funds tracked by Wall St. Rank held Constellium as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.